National and Kapodistrian University of Athens
Μελέτη της επίπτωσης πολυμορφισμών στα γονίδια των αλυσίδων Α και Β του ινωδογόνου και της επίδρασης αυτών στη φλεγμονή, στην ενδοθηλιακή λειτουργία και στους αιμοστατικούς παράγοντες σε ασθενείς με στεφανιαία νόσο
Abstract
dc:descriptionAim: Coronary artery disease is the leading cause of mortality in the modern societies. It is a complex disease and rather theresult of underlying processes such as inflammation, coagulation and impaired endothelial function. Fibrinogen is acoagulation/inflammatory biomarker strongly associated with atherogenesis. Data have reported that the genetic variability onfibrinogen chains may affect the atherosclerotic process and the risk of coronary artery disease (CAD). Therefore, in the presentstudy we examined for the first time the combined effects of the G455A (rs180070) and the G58A (rs2070011) fibrinogen geneticpolymorphisms on prothrombotic profile, endothelial function, inflammatory process and the risk of CAD in a Caucasianpopulation in Greece.Methods: We recruited 422 patients with angiographically documented CAD and 277 controls matched for age and gender duringa period of 5 years. The two polymorphisms were genotyped by polymerase chain reaction (PCR) and appropriate restrictionenzymes HaeIII and AciI. Fibrinogen levels were measured by the Clauss method, D-Dimers levels, factors' (f) V, X activity,thrombin, plasminogen were measured by standard coagulometry techniques. Interleukin-6 (IL-6) and sCD40L were measuredby appropriate enzyme-linked immunosorbent assays (ELISA). High sensitivity C-reactive protein (hsCRP) were measured byan immunophelometry method. Flow-mediated dilatation (FMD) was estimate by the use of ultrasound in the brachial artery.Results: We have found that the 455AA homozygosity was associated with increased fibrinogen levels not only in the controlgroup (p=0.035), but also in the CAD group (p<0.001) compared to the G allele carriers, however, the 58AA subjects had notsignificantly different levels of fibrinogen compared with the 58GG+GA in both groups (p=NS). Moreover, both the 58AA(p=0.016) and 455AA homozygotes (p=0.022) presented with higher levels of D-Dimers in the CAD group. Interestingly, the455AA homozygotes had increased fV activity in the CAD group (p=0.048). However, no significant effects were observed on fXactivity and FMD. The AA homozygosity of rs180070 was associated with significantly higher levels of fibrinogen in both HTNand DM (p=0.05, p=0.04 respectively). Multivariate logistic regression analysis showed that fibrinogen levels >443 mg/dl wereassociated with higher risk for CAD [OR: 3.9, 95% CI, (1.7-9.4, p=0.002)] compared to levels <347 mg/dl in the generalpopulation. Similar associations were observed in HTN and DM patients. The presence of AA genotype (rs180070) was alsosignificantly associated with increased risk of CAD in the general population [OR: 3.2, 95% CI, (1.01-10.1, p=0.049)]. Finally, theAA homozygosity (rs180070) was associated with higher IL-6 an D-dimer, but not hsCRP levels in the general population.Conclusions: Importantly, we have found, that the G455A variant not only increased significantly fibrinogen levels, but also for thefirst time to our knowledge, modified D-Dimers levels as well as fV activity. Therefore, our findings suggest that these twofibrinogen variants may potentially contribute to the initiation and progression of atherosclerosis in subjects with or without stableangina pectoris via their effects on the coagulation cascade, but not on endothelial function. Additionally to the previous, fV andfX activity could be potential risk factors for increased vessel disease as well as MI. Our study showed that fibrinogen was anindependent predictor of CAD and this strongly related to its levels (>443 mg/dl) in both DM and HTN. Additionally, the AAhomozygosity of rs180070 was associated with higher fibrinogen, IL-6, D-dimer levels and risk of CAD in the overall cohort. Inthe overall cohort as well as in hypertensive patients, hsCRP was found to be elevated in the high-fibrinogen subgroup.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papagaorgiou, Nikolaos
- Παπαγεωργίου, Νικόλαος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40224